Ahmed Ferchiou

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Staphylococcus Aureus

Antimicrobial Resistance

Atopic Dermatitis

Top Venues

Antibiotics (Basel, Switzerland)

Animals : an open access journal from MDPI

Veterinary sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Ferchiou, Youba Ndiaye, Mostafa A Mandour, Nicolas Herman, Guillaume Lhermie, Didier Raboisson
The Marginal Abatement Cost of Antimicrobials for Dairy Cow Mastitis: A Bioeconomic Optimization Perspective. Veterinary sciences 10 (2) (2023)
Rodolphe Robcis, Ahmed Ferchiou, Mehdi Berrada, Didier Raboisson
Management of Digital Dermatitis in Dairy Herds: Optimization and Time Allocation. Animals : an open access journal from MDPI 13 (12) (2023)
Rodolphe Robcis, Ahmed Ferchiou, Mehdi Berrada, Didier Raboisson
Management of Digital Dermatitis in Dairy Herds: Optimization and Time Allocation. Animals : an open access journal from MDPI 13 (12) (2023)
Ahmed Ferchiou, Youba Ndiaye, Mostafa A Mandour, Nicolas Herman, Guillaume Lhermie, Didier Raboisson
The Marginal Abatement Cost of Antimicrobials for Dairy Cow Mastitis: A Bioeconomic Optimization Perspective. Veterinary sciences 10 (2) (2023)
Diego Manriquez, Maiara Costa, Ahmed Ferchiou, Didier Raboisson, Guillaume Lhermie
Multi-Criteria Decision Analysis for Assessing Social Acceptance of Strategies to Reduce Antimicrobial Use in the French Dairy Industry. Antibiotics (Basel, Switzerland) 12 (1) (2022)
Diego Manriquez, Maiara Costa, Ahmed Ferchiou, Didier Raboisson, Guillaume Lhermie
Multi-Criteria Decision Analysis for Assessing Social Acceptance of Strategies to Reduce Antimicrobial Use in the French Dairy Industry. Antibiotics (Basel, Switzerland) 12 (1) (2022)
Didier Raboisson, Ahmed Ferchiou, Tifenn Corre, Sylvain Perez, Pierre Sans, Guillaume Lhermie, Marie Dervillé
Could Contracts between Pharmaceutical Firms and French Veterinarians Bias Prescription Behaviour: A Principal-Agency Theory Approach in the Context of Oligopolies. Antibiotics (Basel, Switzerland) 10 (2) (2021)